This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2023 Nov 1;159(11):1177-1178.

doi: 10.1001/jamadermatol.2023.3846.

Dupilumab, Atopic Dermatitis, and Mycosis Fungoides-New Insights on an Evolving Story

Affiliations

PMID: 37851433
DOI: 10.1001/jamadermatol.2023.3846

Editorial

Dupilumab, Atopic Dermatitis, and Mycosis Fungoides-New Insights on an Evolving Story

Joan Guitart. JAMA Dermatol. 2023.

. 2023 Nov 1;159(11):1177-1178.

doi: 10.1001/jamadermatol.2023.3846.

Author

Affiliation

¹ Department of Dermatology, Northwestern University Feinberg Medical School, Chicago, Illinois.

PMID: 37851433
DOI: 10.1001/jamadermatol.2023.3846

No abstract available

PubMed Disclaimer

Comment on

Dupilumab-Associated Lymphoid Reactions in Patients With Atopic Dermatitis.
Boesjes CM, van der Gang LF, Bakker DS, Ten Cate TA, Spekhorst LS, de Graaf M, van Dijk MR, de Bruin-Weller MS. Boesjes CM, et al. JAMA Dermatol. 2023 Nov 1;159(11):1240-1247. doi: 10.1001/jamadermatol.2023.3849. JAMA Dermatol. 2023. PMID: 37851456 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems